US Stock MarketDetailed Quotes
UNCY Unicycive Therapeutics
- 0.4373
- -0.0408-8.53%
Trading Nov 14 12:18 ET
45.39MMarket Cap-950P/E (TTM)
0.4790High0.4139Low1.71MVolume0.4781Open0.4781Pre Close754.88KTurnover2.79%Turnover RatioLossP/E (Static)103.80MShares1.818052wk High1.63P/B26.87MFloat Cap0.202052wk Low--Dividend TTM61.45MShs Float8.7300Historical High--Div YieldTTM13.62%Amplitude0.2020Historical Low0.4400Avg Price1Lot Size
Unicycive Therapeutics Key Stats
EPS
According to the latest financial report of Unicycive Therapeutics, the latest earnings per share (TTM) for the company is -0.15. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Unicycive Therapeutics's free cash flow? The latest report shows it as -6.34M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Unicycive Therapeutics shows that the company's current ratio is 3.37, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Unicycive Therapeutics, the quick ratio is 3.19, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Unicycive Therapeutics? The latest ROE figure is -256.15%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Unicycive Therapeutics, the total asset return on investment (ROA) is 6.27%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Unicycive Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Unicycive Therapeutics, the net profit margin is -2.16K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data